The translocator protein ligands as mitochondrial functional modulators for the potential anti-Alzheimer agents
Autor: | Mohammad Morshed, Sang Min Lim, Jiyoun Lee, TaeHun Kim, Jae Y Lee, Ha E Lee, Ae N Pae, Suengmok Cho, Sung J Cho, Ashwini M. Londhe, Ji W Lim, Hayoung Hwang |
---|---|
Rok vydání: | 2021 |
Předmět: |
Cell Survival
Drug Evaluation Preclinical RM1-950 Ligands 01 natural sciences Protein Aggregation Pathological Small Molecule Libraries Mice Transcriptional Regulator ERG Alzheimer Disease Drug Discovery Translocator protein medicine Animals Humans Viability assay function modulators translocator protein ligand Cells Cultured Pharmacology Virtual screening Amyloid beta-Peptides biology Molecular Structure 010405 organic chemistry Chemistry Biological activity General Medicine medicine.disease Small molecule 0104 chemical sciences Cell biology Mitochondria 010404 medicinal & biomolecular chemistry Mitochondrial toxicity Disease Models Animal Neuroprotective Agents Mitochondrial permeability transition pore biology.protein Therapeutics. Pharmacology Pharmacophore Alzheimer’s disease Research Article Research Paper |
Zdroj: | Journal of Enzyme Inhibition and Medicinal Chemistry article-version (VoR) Version of Record Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 831-846 (2021) |
DOI: | 10.6084/m9.figshare.14267582 |
Popis: | Small molecule modulators of mitochondrial function have been attracted much attention in recent years due to their potential therapeutic applications for neurodegenerative diseases. The mitochondrial translocator protein (TSPO) is a promising target for such compounds, given its involvement in the formation of the mitochondrial permeability transition pore in response to mitochondrial stress. In this study, we performed a ligand-based pharmacophore design and virtual screening, and identified a potent hit compound, 7 (VH34) as a TSPO ligand. After validating its biological activity against amyloid-β (Aβ) induced mitochondrial dysfunction and in acute and transgenic Alzheimer’s disease (AD) model mice, we developed a library of analogs, and we found two most active compounds, 31 and 44, which restored the mitochondrial membrane potential, ATP production, and cell viability under Aβ-induced mitochondrial toxicity. These compounds recovered learning and memory function in acute AD model mice with improved pharmacokinetic properties. |
Databáze: | OpenAIRE |
Externí odkaz: |